LetterResearch CorrespondenceAortic Stenosis With Severe Asymmetric Septal Hypertrophy: A Novel Management Strategy to Improve TAVR Outcomes
Research Correspondence
Under an Elsevier user license
open archive
Cited by (0)
Please note: Dr. Tang has served as a physician proctor for Edwards Lifesciences and Medtronic. Dr. Dangas has served as a clinical trial investigator for Medtronic. Dr. Sharma has served on the Speakers Bureau for Abbott Vascular, Boston Scientific, Abiomed, and Cardiovascular Systems. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2019 by the American College of Cardiology Foundation. Published by Elsevier.